Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatments-Reference-Cited by-同舟云学术

Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatments

Published:2021-01-15 Issue:2 Volume:100 Page:e24156
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Oh Sang-Bo,Park Kwonoh,Kim Jae-Joon,Oh So-Yeon,Jung Ki-Sun,Park Byung-Soo,Son Gyung-Mo,Kim Hyun-Sung,Kim Dong-Hyun,Jung Hyuk-Jae,Lee Sang-Su

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference19 articles.

1. Cancer statics, 2019;Siegel;CA Cancer J Clin,2019

2. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004

3. Long-term outcomes of totally implantable venous access devices;Wang;Support Care Cancer,2017

4. Complications and management of implanted venous access catheters;Lokich;J Clin Oncol,1985

5. Long-term, totally implantable central venous access ports conneted to a Groshong catheter for chemotherapy of solid tumors: experience from 178 cases using a single type of device;Biffi;Eur J Cancer,1997

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatments: Erratum;Medicine;2024-08-02

2. Factors associated with unscheduled venous access port removal in cancer patients;Gulhane Medical Journal;2024-06-13

3. Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review;BMC Cancer;2024-04-19

4. Vascular access device type for systemic anti-cancer therapies in cancer patients: A scoping review;Critical Reviews in Oncology/Hematology;2024-04

5. Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer;Frontiers in Oncology;2022-12-02